The mission of the Medical Oncology Department is comprehensive care of oncological patients. This multidisciplinary approach helps the patient through diagnosis, treatment, outcome and follow-up.
The professional team accompanies the cancer patient throughout the whole process of the disease, through a direct and personal relationship based on mutual trust, attending to the pathology associated with their disease and any complications that arise due to treatment, as well as collaborating in the emotional support of patients and relatives.
The IVO’s specialization in oncology allows the service areas to be structured and organized by healthcare areas according to the type of tumours, each of which has specialists preferentially dedicated to the treatment of that type of tumour in which they have extensive experience: head and neck tumours, brain tumours, tumours of the digestive system, gynaecological tumours, haematological tumours, breast tumours, melanoma, lung tumours, sarcomas and urological tumours.
The medical oncologist has the principal function of coordinating and customizing the most appropriate medical treatment for each patient. There are many means of dealing with oncological diseases: surgery, radiation therapy, systemic treatments, or any combination of the three. The main systemic treatment is chemotherapy, whose objective is to eliminate cancer cells. There are also others, such as hormone therapy, immunotherapy and targeted therapies (anti-target drugs).
It will be the staff in the different Tumour Committee teams that study the different therapeutic strategies and decide which is the optimum or most efficient treatment for each patient. The Tumour Committees are regulated under established protocols and are made up of a multidisciplinary team of professionals from the main specialities, depending upon the type of tumour: medical oncology, radiation oncology, surgery, radiology, nuclear medicine, pathology, molecular biology, psychology, nursing, etc. The Medical Oncology Service is, in many respects, a key part of coordination and collaboration among the various units at the hospital.
The Day Hospital is the outpatient unit where the treatments are administered intravenously to patients with oncohaematologic diseases that require such treatments. The facilities and equipment in the unit have recently been refurbished to create a bright and quiet space making the patient’s stay more pleasant. It currently has a large compartmentalized treatment area, two single rooms and an area with two beds for patients being treated within phase I clinical trials, that require specific observation.
Oncological Nursing is essential in the care of the patient with cancer, thus, the team of nurses and orderlies at the Day Hospital has a high degree of expertise, knowledge, sensitivity and understanding of the situation that cancer patients are in. Furthermore, they have the necessary skills to carry out their care work with special attention to the control and monitoring of symptoms and the side effects of the treatments, as well as offering emotional support.
The Medical Oncology Service coordinates the care of patients with symptomatic-palliative treatments and terminal patients, both during their hospital stay and in home hospitalization.
The Genetic Counselling Unit (UCG) is part of the Medical Oncology Service. Their mission it to assess the risk of developing hereditary cancer and advise how to prevent it. To that end, they carry out genetic tests aimed at identifying if a patient is host to any genetic mutations. The unit is integrated by a broad multidisciplinary team of professionals from various disciplines: medical oncology, molecular biology, pathology, psycho-oncology, surgery, gynaecology, and nursing.
The research activity of the Medical Oncology Service is a national referent. It is currently participating annually in over 100 clinical trials in oncology drugs in the different types of tumours in both Phase I and Phases II and III: breast cancer, gynaecological cancer, prostate cancer, lung cancer, sarcoma, melanoma, etc. The Medical Oncology Service at the IVO has participated in the development of most of the new anti-cancer drugs marketed in the past 20 years and is currently one of the centres in Spain with the most oncology drug clinical trials.
The Instituto Valenciano de Oncología Foundation has an accredited slot for specialized medical training (MIR) residencies in Medical Oncology. See call for tender.
Head of Department
Dr. Vicente Guillem Porta
Head of Department
Dr. Vicente Guillem Porta
Heads of Section
Dr. Miguel Ángel Climent Duran
Dr. Joaquín Gavila Gregori
Dra. Teresa Olmos Martinez
Dr. Salvador Blanch Tormo
Dr. Ángel Luis Guerrero Zotano
Dra. Mª José Juan Fita
Dr. Javier Lavernia Giner
Dr. Ignacio Romero Noguera
Dra. Virtudes Soriano Teruel
Dr. Ricardo Yaya Tur
Dr. Sergio Sandiego Contreras
Dra. Desamparados Ines Iraola Lliso
Dr. Marcos Melian Sosa
Maria Asunción Algarra García
Pablo Álvarez Rodríguez
Héctor Augusto Aguilar Andino
Edwin Mateo Quispe Bellido
Scarlet Berenice Urtecho Suarez
Day Hospital pictures